Meet and network with the key influencers shaping the law, policy and proceedings of Paragraph IV litigation

Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation.

As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.

Sign up and stay tuned for more exciting program announcements and our incredible speaker line-up!


Patent attorneys and litigators (in-house & law firms) who represent:

  • Brand name pharmaceutical companies
  • Generic pharmaceutical companies
  • Biopharmaceutical companies


“This is the best high-level conference on Paragraph IV disputes…”

Senior VP, Intellectual Property

Endo Pharmaceuticals

“…the smaller breakout sessions allow participants to tailor their conference experience to meet their specific needs, and exchange ideas in an intimate and dynamic environment”

Senior VP and Head, Intellectual Property

Eagle Pharmaceuticals

Attend the conference that the “Who’s Who” of Hatch-Waxman litigators have designated as the forum which sets the standards for Paragraph IV practice. Register now and be part of the prestigious meeting of the minds.

Registration is Now Open. Enjoy Early Bird Rates to Save $400!

Event Contacts

Sponsorship Opportunities:

American Conference Institute
Email Us

Media Partnership Opportunities:

Linda Lam
Email Us

Programme Information and Speaking:

Joseph Gallagher
Email Us


Conrad Hotel

102 North End Avenue, New York, NY 10282

Book Now